# A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).

> **NCT05354596** · NA · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 138 (estimated)

## Conditions studied

- Lung Cancer
- Metastases to Lung
- Radiotherapy Side Effect

## Interventions

- **PROCEDURE:** STRICT LUNG
- **PROCEDURE:** STAR LUNG

## Key facts

- **NCT ID:** NCT05354596
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2033-05-01
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2023-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354596, "A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05354596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*